Literature DB >> 16299405

Angiogenesis and the growth potential of craniopharyngiomas.

Sergio Vidal1, Bernd W Scheithauer, Kalman Kovacs, Ricardo V Lloyd.   

Abstract

The present study was performed to evaluate the role of neovascularization on the behavior of craniopharyngiomas as well as the contribution of endothelial cell proliferation and migration in the remodeling and expansion of the vascular network associated with angiogenesis. Fourteen primary tumors were studied, all of the adamantinomatous type. CD34 immunostaining, an endothelial cell marker, localized vessels within the connective tissue stroma. MIB-1 immunopositivity was apparent in the nuclei of neoplastic cells, few endothelial cells, and stromal elements. MIB-1 counts were higher in epithelial than connective tissue cells. A positive correlation was found between the number of MIB-1 immunopositive cells and microvessel density (MVD). Immunohistochemistry demonstrated that integrin alphavbeta3 expression was restricted to tumor vasculature; the tumor cells were immunonegative. Only 2.5% of vessels detected with CD34 were immunopositive for integrin alphavbeta3. At present, no therapeutic implications can be drawn from our observations. More studies are needed to assess whether integrin alphavbeta3 antagonists or drugs that arrest the cell cycle of endothelial cells can inhibit angiogenesis in craniopharyngiomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299405     DOI: 10.1385/ep:16:3:219

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  47 in total

Review 1.  Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation.

Authors:  Daniel J Brat; Amilcar Castellano-Sanchez; Balveen Kaur; Erwin G Van Meir
Journal:  Adv Anat Pathol       Date:  2002-01       Impact factor: 3.875

2.  Expression of vascular permeability factor in craniopharyngioma.

Authors:  J Vaquero; M Zurita; S de Oya; S Coca; C Morales; C Salas
Journal:  J Neurosurg       Date:  1999-11       Impact factor: 5.115

3.  High microvessel density in primitive neuroectodermal brain tumors of childhood.

Authors:  M A Grotzer; R Wiewrodt; A J Janss; H Zhao; A Cnaan; L N Sutton; L B Rorke; P C Phillips
Journal:  Neuropediatrics       Date:  2001-04       Impact factor: 1.947

4.  The association between tumour progression and vascularity in the oral mucosa.

Authors:  S Pazouki; D M Chisholm; M M Adi; G Carmichael; M Farquharson; G R Ogden; S L Schor; A M Schor
Journal:  J Pathol       Date:  1997-09       Impact factor: 7.996

5.  Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

Authors:  P Kunkel; U Ulbricht; P Bohlen; M A Brockmann; R Fillbrandt; D Stavrou; M Westphal; K Lamszus
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

6.  Recurrent meningiomas--the immunohistochemical analysis of angiogenesis and cellular proliferation. Preliminary study.

Authors:  E Izycka-Swieszewska; R Rzepko; J Borowska-Lehman; E Baranowska; D Warzocha
Journal:  Folia Neuropathol       Date:  1999       Impact factor: 2.038

7.  Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors.

Authors:  S K Kim; K C Wang; S H Shin; G Choe; J G Chi; B K Cho
Journal:  Childs Nerv Syst       Date:  2001-09       Impact factor: 1.475

8.  Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.

Authors:  C C Kumar; M Malkowski; Z Yin; E Tanghetti; B Yaremko; T Nechuta; J Varner; M Liu; E M Smith; B Neustadt; M Presta; L Armstrong
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

10.  Necrosis as a prognostic factor in glioblastoma multiforme.

Authors:  F G Barker; R L Davis; S M Chang; M D Prados
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860

View more
  2 in total

1.  Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis.

Authors:  Oksan Karal-Yilmaz; Abdulkadir Ozkan; Emel Akgun; Manolya Kukut; Kemal Baysal; Timucin Avsar; Turker Kilic
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

2.  Chordoid meningioma: a report of ten cases.

Authors:  Martha Lilia Tena-Suck; Miguel Angel Collado-Ortìz; Citlaltepetl Salinas-Lara; Rabindhranath García-López; Noemi Gelista; Daniel Rembao-Bojorquez
Journal:  J Neurooncol       Date:  2010-01-22       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.